
Pharmacists see it frequently-customers making multiple purchases of ephedrine or pseudoephedrine products and seeking out the highest dosage.

Pharmacists see it frequently-customers making multiple purchases of ephedrine or pseudoephedrine products and seeking out the highest dosage.

Here's the latest on the second biosimilar in line to receive FDA approval.

Where is retail pharmacy headed? A look at where it's coming from may shed some light.

President Obama this week rejected a proposal from the nation’s governors that sought to fight the heroin epidemic by limiting the number of painkillers doctors could prescribe.

With 2016 well underway, pharmacies of all sizes should review recent regulatory updates to ensure compliance with rules already in effect, and preparation for those to be implemented soon. Three, in particular, warrant a close look.

Recently, the American Society of Health-System Pharmacists and the American Pharmacists Association approved a new standard for PGY1 community-based residency training programs.

What do you do when you've got half a dozen warring paradigms inside your head?

This year's APhA award goes to one of the most widely cited pharmaceutical scientists in the world.

Reimbursement for MTM services is still a challenge for many. An insurance executive offers some well-vetted tips.

Primary nonadherence has been a barrier to optimal hypertension management. Claims data can help identify patients who need interventions to improve compliance.

Test your knowledge of pharmacy history. Questions drawn from February 10, 2016 160th Anniversary issue of Drug Topics.

Every bench pharmacist can tell this story. Every. Single. One.

New Rx, new indications, new formulations, and new generics

Products for adults and children line pharmacy shelves, with plenty of child-friendly options for parents teaching oral hygiene to the young.

As Drug Topics celebrates its 160th anniversary this year, we want to show you how far the profession of pharmacy has come.

The profession of pharmacy goes back further than you think. Way further.

While his peers play pinochle and shuffleboard, Fred Mayer brings endless energy and enthusiasm to the practice of pharmacy and public health.

As specialized pharmacy education has evolved through the years, the value that pharmacists contribute to healthcare has increased exponentially.

Health-system pharmacists help improve patient care, boost patient outcomes, reduce readmission rates, and lower costs - and savvy administrators know it.

Pharmacists are drug specialists. If their duty is to use their knowledge in service to patients, can they be sued for speaking up?

Back in 1974, Drug Topics foretold the battle fought by corporate America over state regulation of pharmacy ownership. Here's what we said then - and here's how it turned out.

Researchers found that rates of DVT and PE were significantly lower among patients who received preoperative chemoprophylaxis than in those who did not.

Because of concerns about adverse effects, training through the Addyi REMS program is required for prescribers and pharmacies that want to participate in the medication use process for this drug.

Five states legally recognize assisted suicide in the face of terminal illness. More are likely to follow.

A hundred years ago, Drug Topics was a pocket-sized monthly, circulation: 12,000; yearly price: 25 cents. While some of its content seems antiquated now, some seems eerily familiar. And the illustrations? A hoot!

Less than a week after FDA announced several measures aimed at curbing opioid abuse, Walgreens announced it would install safe medication disposal kiosks in more than 500 drugstores in 39 states and Washington, D.C.

The average salary for pharmacists in the United States can vary greatly by location.

Pharmacists need to unionize. You've heard all the reasons. Here's another one -- and it's time-sensitive.

After secretly shopping at 200 stores in six states, "Consumer Reports" announced its findings, and they make for very interesting reading.

The U. S. healthcare system saved a record $254 billion from generic drugs in 2014 and $1.68 trillion from 2005 to 2014, but much more can be done.